| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -7.82M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PASG returned -41.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -62.4% |
| 1 year | -41.1% |
| 5 years | -98.2% |
| All-time high | $546.60 (Jun 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PASG would be worth today ›No. Passage Bio, Inc. has not paid a dividend in the past 12 months.
Passage Bio, Inc. stock trades on NASDAQ under the ticker symbol PASG.
Passage Bio, Inc. is part of the Healthcare sector.
Passage Bio, Inc. has a market cap of 14.29M USD, based on the latest quote.
